TiO2's nano-form use in spray sunscreens is already prohibited in the EU under the Cosmetics Regulation, but broader restrictions potentially extending to other cosmetic categories could be imposed down the line following a proposal from ECHA's Committee for Risk Assessment that the ingredient be CLP-classified as a suspected carcinogen when inhaled. There are also potential ramifications stateside to consider.
The European Chemicals Agency is poised to propose that titanium dioxide be categorized as a suspected carcinogen when inhaled, which could lead to an EU ban on the ingredient's use in sunscreen spray products and other SPF-containing cosmetics that may expose users to airborne particles.
According to a June announcement, ECHA's Committee for Risk Assessment (RAC) has concluded that available scientific evidence meets criteria in...
In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Weak demand for virus-blocking nasal sprays since the pandemic has left Austrian biotech Marinomed with mounting debts. The company has applied for restructuring proceedings with an Austrian court in an attempt to secure its future.
Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
